4//SEC Filing
KOSKI ROBERT C 4
Accession 0001493152-21-004423
CIK 0001174940other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:35 PM ET
Size
10.0 KB
Accession
0001493152-21-004423
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
KOSKI ROBERT C
Director10% Owner
Transactions
- Gift
Common Stock
2021-01-02−30,000→ 212,839 total - Award
Non-Employee Director Option (Right to Buy)
2021-02-18+160,000→ 160,000 totalExercise: $1.20From: 2021-02-18Exp: 2031-02-18→ Common Stock (160,000 underlying)
Holdings
- 53,086(indirect: See Footnote)
Common Stock
- 776,483(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Shares owned directly by Robert C. Koski, a director of the Company.
- [F2]Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (10,760 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (10,760 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (10,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (10,760 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (10,806 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
- [F4]Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeother
Related Parties
1- filerCIK 0001234880
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:35 PM ET
- Size
- 10.0 KB